headshot of Zongqi Xia

Zongqi Xia

Associate Professor
Website Bioengineering Department


Bargiela, D., Bianchi, M.T., Westover, M.B., Chibnik, L.B., Healy, B.C., De Jager, P.L., & Xia, Z. (2017). Selection of first-line therapy in multiple sclerosis using risk-benefit decision analysis. Neurology, 88(7), 677-684.Ovid Technologies (Wolters Kluwer Health). doi: 10.1212/WNL.0000000000003612.

Zhang, T., Goodman, M., Zhu, F., Healy, B., Carruthers, R., Chitnis, T., Weiner, H., Cai, T., De Jager, P., Tremlett, H., & Xia, Z. (2020). Phenome-wide examination of comorbidity burden and multiple sclerosis disease severity. In NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 7(6), (p. 489).Ovid Technologies (Wolters Kluwer Health).United States. doi: 10.1212/NXI.0000000000000864.